Vistagen: Pherine Candidate Proof Of Concept Continues With Fifth Indication
Vistagen Therapeutics, Inc.'s fasedienol shows promise in treating social anxiety; new results expected 2025. Click for my ...
Science Friday5h
The FDA Approves A New, Non-Opioid Painkiller
It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?